Northern Trust’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-41,285
Closed -$5.37K – 4662
2023
Q1
$5.37K Hold
41,285
– – ﹤0.01% 4562
2022
Q4
$6.78K Hold
41,285
– – ﹤0.01% 4608
2022
Q3
$27K Hold
41,285
– – ﹤0.01% 4493
2022
Q2
$100K Sell
41,285
-5,640
-12% -$15.7K ﹤0.01% 4170
2022
Q1
$190K Sell
46,925
-1,537
-3% -$8.43K ﹤0.01% 4151
2021
Q4
$388K Buy
48,462
+5,593
+13% +$65.6K ﹤0.01% 3902
2021
Q3
$827K Sell
42,869
-1,644
-4% -$28.7K ﹤0.01% 3610
2021
Q2
$614K Buy
44,513
+8,581
+24% +$102K ﹤0.01% 3646
2021
Q1
$324K Buy
35,932
+25,889
+258% +$189K ﹤0.01% 3955
2020
Q4
$55K Buy
+10,043
New +$44.4K ﹤0.01% 4224
2020
Q2
– Sell
-10,980
Closed -$25K – 4321
2020
Q1
$25K Hold
10,980
– – ﹤0.01% 4062
2019
Q4
$48K Sell
10,980
-23
-0.2% -$108 ﹤0.01% 4065
2019
Q3
$57K Sell
11,003
-100
-0.9% -$582 ﹤0.01% 4037
2019
Q2
$80K Hold
11,103
– – ﹤0.01% 4007
2019
Q1
$59K Buy
+11,103
New +$54.3K ﹤0.01% 4021
2017
Q2
– Sell
-1,600
Closed -$17K – 4311
2017
Q1
$17K Sell
1,600
-3,138
-66% -$34.1K ﹤0.01% 4169
2016
Q4
$60K Buy
4,738
+65
+1% +$2.39K ﹤0.01% 3986
2016
Q3
$542K Buy
4,673
+468
+11% +$45.6K ﹤0.01% 3494
2016
Q2
$333K Buy
4,205
+230
+6% +$19.9K ﹤0.01% 3599
2016
Q1
$303K Hold
3,975
– – ﹤0.01% 3600
2015
Q4
$356K Buy
3,975
+238
+6% +$22.8K ﹤0.01% 3586
2015
Q3
$419K Buy
3,737
+2,317
+163% +$267K ﹤0.01% 3537
2015
Q2
$144K Buy
+1,420
New +$147K ﹤0.01% 3863

Other funds holding PLXP

Northern Trust's PLXP Position: Q2 2023 in Review

Northern Trust sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2023, closing a stake of 41,285 shares — an estimated $5.37K sold.

Northern Trust first reported a position in PLXP in Q2 2015 and held it in 23 quarters. The position peaked at $827K in Q3 2021. 4 funds tracked by Wall St. Rank hold PLXP as of Q2 2023.

  • Northern Trust reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Northern Trust sold 41,285 PLx Pharma Inc. Common Stock shares in Q2 2023, an estimated $5.37K.
  • Northern Trust first reported a position in PLx Pharma Inc. Common Stock in Q2 2015 and held it in 23 quarters.
  • Northern Trust's PLx Pharma Inc. Common Stock position peaked at $827K in Q3 2021.
  • 4 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2023.

Based on Northern Trust's 13F filing for Q2 2023, filed 11 Aug 2023.